摘要
目的:探究老年轻中度慢性持续期哮喘患者接受中西医结合治疗的价值。方法:以100例老年轻中度慢性持续期哮喘患者为研究对象,时间为2016年1月-2017年12月,以远程随机化法分组,其中对照组实施常规西药治疗,实验组则实施中西医结合治疗,分析两组老年轻中度慢性持续期哮喘患者治疗的结果。结果:实验组老年轻中度慢性持续期哮喘患者的总有效率(94.00%)明显高于对照组的总有效率(80.00%),差异有统计学意义(P<0.05);两组患者治疗后的血氧饱和度、一秒用力呼气容积均较治疗前升高,其呼吸峰值流速变异率较治疗前降低,其中实验组治疗后的血氧饱和度、一秒用力呼气容积高于对照组,其呼吸峰值流速变异率低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率相比,差异无统计学意义(P>0.05)。结论:老年轻中度慢性持续期哮喘患者接受中西医结合治疗,可取得较好的效果。
Objective:To investigate efficacy of the integrative medicine on mild to moderate chronic persistent asthma in elderly.Methods:From January 2016 to December 2017,100 cases were divided into two groups.The control group was given conventional western medicine;and the experimental group was given the integrative medicine.Results:The total efficiency was 94.00%in the experimental group,higher than 80.00%in the control group,P<0.05.After treatment,oxygen saturation and FEV1 in two groups were higher than before treatment,and PEF mutation probability was lower than that before treatment.After treatment,oxygen saturation and FEV1 in the experimental group were higher than those in the control group,and PEF mutation probability was lower than that in the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:The integrative medicine on mild to moderate chronic persistent asthma in elderly shows good effects.
出处
《中医临床研究》
2019年第26期26-28,共3页
Clinical Journal Of Chinese Medicine
关键词
中西医结合
老年患者
轻中度慢性持续期哮喘
The integrative medicine
Elderly
Mild to moderate chronic persistent asthma
